Symptoms and Clinical Presentations of Small Intestinal Bacterial Overgrowth (SIBO)
Core Gastrointestinal Symptoms
- Bloating and abdominal distention are the hallmark symptoms of SIBO, characteristically worsening after eating, according to the American Gastroenterological Association 1
- Flatulence and excessive gas production result directly from bacterial fermentation of carbohydrates in the small intestine, contributing to symptom severity 1
- Abdominal pain and discomfort occur frequently, particularly shortly after eating, in patients with SIBO, as reported by the European Society of Gastrointestinal Motility 2
Severe Manifestations (Advanced Disease)
- Steatorrhea (fatty stools) develops when bacterial overgrowth causes bile salt deconjugation and pancreatic enzyme degradation, leading to malabsorption, as noted by the American College of Gastroenterology 2
- Weight loss and malnutrition result from malabsorption in advanced SIBO cases, although these are uncommon in mild presentations, according to the National Institute of Diabetes and Digestive and Kidney Diseases 2, 1
- Nutritional deficiencies, including fat-soluble vitamins (A, E, D, K), may occur due to malabsorption, causing symptoms such as night blindness and dry skin, as reported by the European Society of Clinical Nutrition and Metabolism 2
Important Clinical Distinctions
- The symptoms of SIBO overlap significantly with irritable bowel syndrome (IBS), making clinical distinction challenging without diagnostic testing, such as breath tests or small bowel aspiration, as stated by the American Gastroenterological Association 1
- Normal inflammatory markers, such as fecal calprotectin, are expected in SIBO, and elevated levels should prompt investigation for alternative diagnoses, according to the European Crohn’s and Colitis Organisation 1, 3
Pathophysiologic Symptom Mechanisms
- Impaired migrating motor complex (MMC) prevents clearance of intestinal debris, predisposing to bacterial overgrowth and gut stasis, as explained by the American Neurogastroenterology and Motility Society 2
- Bacterial fermentation of unabsorbed carbohydrates produces hydrogen and methane gas, causing bloating and flatulence, according to the International Scientific Association for Probiotics and Prebiotics 1
- Bile salt deconjugation by anaerobic bacteria leads to fat malabsorption and steatorrhea in advanced cases, as reported by the American College of Gastroenterology 2
Risk Factor Considerations
- Patients with underlying conditions, such as prior gastrointestinal surgery, pancreatic exocrine insufficiency, diabetes mellitus, and motility disorders, are more likely to develop SIBO, as noted by the American Gastroenterological Association 1, 2
Diagnosis and Clinical Features of Small Intestinal Bacterial Overgrowth (SIBO)
Symptom Differentiation
- Abdominal pain and discomfort that arise shortly after meals are characteristic of SIBO and help distinguish it from other functional gastrointestinal disorders where pain patterns are more variable. 4
Diagnostic Testing Requirements
- The presence of bloating and excessive gas alone is insufficient to confirm SIBO because these symptoms are nonspecific and occur in many gastrointestinal conditions; objective testing is mandatory. 4
- Definitive diagnosis of SIBO requires objective testing such as glucose or lactulose breath testing, or, in selected cases, small‑bowel aspirate culture to detect bacterial overgrowth. 4
Prevalence in Functional Bowel Disorder Population
- Up to 30 % of patients presenting with functional bowel symptoms (e.g., IBS‑like complaints) may have underlying SIBO, highlighting the need for diagnostic evaluation in this group. [5][4]
Diarrhea Mechanisms
- Diarrhea is a common manifestation of SIBO and results from several mechanisms, including bile‑salt deconjugation, direct mucosal irritation by bacterial metabolites, and osmotic effects of unabsorbed carbohydrates. 5
High‑Risk Clinical Contexts
- SIBO should be strongly suspected in individuals with predisposing conditions that impair the migrating motor complex, such as prior gastrointestinal surgery (especially gastric bypass or loss of the ileocecal valve), chronic pancreatitis, diabetes mellitus with autonomic neuropathy, scleroderma, chronic proton‑pump inhibitor use, opioid therapy, or any disorder causing intestinal dysmotility. 5